Cargando…
Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
Glioblastoma multiforme are highly malignant brain tumours with frequent genetic and epigenetic alterations. The poor clinical outcome of these tumours necessitates the development of new treatment options. Immunotherapies for glioblastoma multiforme including PD1/PD-L1 inhibition are currently test...
Autores principales: | Heiland, Dieter Henrik, Haaker, Gerrit, Delev, Daniel, Mercas, Bianca, Masalha, Waseem, Heynckes, Sabrina, Gäbelein, Annette, Pfeifer, Dietmar, Carro, Maria Stella, Weyerbrock, Astrid, Prinz, Marco, Schnell, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522061/ https://www.ncbi.nlm.nih.gov/pubmed/28178682 http://dx.doi.org/10.18632/oncotarget.15031 |
Ejemplares similares
-
The integrative metabolomic-transcriptomic landscape of glioblastome multiforme
por: Heiland, Dieter Henrik, et al.
Publicado: (2017) -
Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme
por: Heynckes, Sabrina, et al.
Publicado: (2017) -
Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiforme
por: Heiland, Dieter Henrik, et al.
Publicado: (2017) -
Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme
por: Heynckes, Sabrina, et al.
Publicado: (2019) -
Integrative Network-based Analysis of Magnetic Resonance Spectroscopy and Genome Wide Expression in Glioblastoma multiforme
por: Heiland, Dieter Henrik, et al.
Publicado: (2016)